Skip to main content
Clinical Trials/CTRI/2023/05/053201
CTRI/2023/05/053201
Recruiting
未知

Intraoperative Dexmedetomidine for preventing Postoperative Delirium in Women scheduled for malignancy surgery : A Comparison of two maintainence dose

niversity College of Medical Siences0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity College of Medical Siences
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversity College of Medical Siences

Eligibility Criteria

Inclusion Criteria

  • 1\. Adult female patients ( \>18 years of age)
  • 2\. ASA I to III
  • 3\. Baseline Mini Mental State Examination (MMSE) \> 24
  • 4\. Malignancy surgery expected to last \> 90 min

Exclusion Criteria

  • Pregnancy, trauma, emergency surgery and obvious infections
  • Alcohol/drug abuse
  • On beta blocker therapy
  • Contraindications for dexmedetomidine administration e.g. sick sinus syndrome ,
  • secondary heart blocks , hepatic dysfunction , renal dysfunction requiring dialysis or
  • allergy to dexmedetomidine
  • Known case of neurological or psychiatric disorders (Parkinsonism, Alzheimer’s
  • Patients receiving drugs which predispose to the development of POD like
  • anticholinergics, opioids and psychoactive drugs, e.g., cocaine, heroin, Lysergic acid
  • diethylamide (LSD).

Outcomes

Primary Outcomes

Not specified

Similar Trials